准确度不断提高:针对胆管癌的向治疗的更新
Giulia Tesini1,2, Halima Ibrahim3, Lorenza Rimassa2,4
1School of Cancer Sciences, University of Glasgow, Glasgow, UK.
Hepatology (Baltimore, Md.)
|September 22, 2025
概括
下一代测序 (NGS) 识别了胆道癌症 (BTC) 的可操作目标. 向药物提供临床益处,并建议高级BTC患者进行第一线治疗后的治疗.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 精准医学是一门精准的医学.
背景情况:
- 胆道癌症 (BTC) 治疗在基因组分析方面取得了进展.
- 下一代测序 (NGS) 在约50%的BTC患者中识别出可操作的分子变化.
- 肝脏内胆管癌显示出这些变化的发生率最高.
研究的目的:
- 审查高级BTC中向药物的临床实用性.
- 将向药物试验结果与临床实践进行比较.
- 为NGS无法访问的病例概述单基因测试策略.
主要方法:
- 针对BTC的向治疗的临床试验数据的审查.
- 分析单基因测试产量和治疗影响.
- 讨论BTC精密医学的未来方向.
主要成果:
- 向药物提供了可管理的安全性概况的临床益处.
- 在一线治疗失败后,建议针对高级BTC患者进行向治疗.
- NGS对于识别可采取行动的改变至关重要,指导治疗决策.
结论:
- 精准医学,特别是有针对性的疗法,正在改变BTC治疗.
- 将向药物整合到治疗算法中,需要仔细考虑耐药机制和新点.
- 未来的研究应该专注于新的策略和新发现的可操作的改变,以改善患者的治疗结果.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.7K
09:11Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.1K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
